346 related articles for article (PubMed ID: 9457428)
41. ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases.
Baz Morelli A; Becher D; Koernig S; Silva A; Drane D; Maraskovsky E
J Med Microbiol; 2012 Jul; 61(Pt 7):935-943. PubMed ID: 22442293
[TBL] [Abstract][Full Text] [Related]
42. Genetic therapy for HIV/AIDS.
Poluri A; van Maanen M; Sutton RE
Expert Opin Biol Ther; 2003 Sep; 3(6):951-63. PubMed ID: 12943454
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.
VandenDriessche T; Chuah MK; Chiang L; Chang HK; Ensoli B; Morgan RA
J Virol; 1995 Jul; 69(7):4045-52. PubMed ID: 7769662
[TBL] [Abstract][Full Text] [Related]
44. New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.
Sautto GA; Diotti RA; Wisskirchen K; Kahle KM
J Immunol Res; 2017; 2017():3104719. PubMed ID: 28758132
[No Abstract] [Full Text] [Related]
45. Simulations for designing and interpreting intervention trials in infectious diseases.
Halloran ME; Auranen K; Baird S; Basta NE; Bellan SE; Brookmeyer R; Cooper BS; DeGruttola V; Hughes JP; Lessler J; Lofgren ET; Longini IM; Onnela JP; Özler B; Seage GR; Smith TA; Vespignani A; Vynnycky E; Lipsitch M
BMC Med; 2017 Dec; 15(1):223. PubMed ID: 29287587
[TBL] [Abstract][Full Text] [Related]
46. Genetics of infectious diseases: hidden etiologies and common pathways.
Orlova M; Di Pietrantonio T; Schurr E
Clin Chem Lab Med; 2011 Sep; 49(9):1427-37. PubMed ID: 21619464
[TBL] [Abstract][Full Text] [Related]
47. Genetics and Genomics of Pathogens: Fighting Infections with Genome-Sequencing Technology.
Plavskin A
Medsurg Nurs; 2016; 25(2):91-6. PubMed ID: 27323467
[TBL] [Abstract][Full Text] [Related]
48. Clinical metagenomics.
Chiu CY; Miller SA
Nat Rev Genet; 2019 Jun; 20(6):341-355. PubMed ID: 30918369
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line.
Michienzi A; Conti L; Varano B; Prislei S; Gessani S; Bozzoni I
Hum Gene Ther; 1998 Mar; 9(5):621-8. PubMed ID: 9551610
[TBL] [Abstract][Full Text] [Related]
50. Deadly infectious diseases such as Ebola: the parachute paradigm.
Lagier JC; Raoult D
Clin Microbiol Infect; 2015 May; 21(5):389-90. PubMed ID: 25770772
[No Abstract] [Full Text] [Related]
51. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
Winthrop KL; Mariette X; Silva JT; Benamu E; Calabrese LH; Dumusc A; Smolen JS; Aguado JM; Fernández-Ruiz M
Clin Microbiol Infect; 2018 Jun; 24 Suppl 2():S21-S40. PubMed ID: 29447987
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic nucleic acids: current clinical status.
Sridharan K; Gogtay NJ
Br J Clin Pharmacol; 2016 Sep; 82(3):659-72. PubMed ID: 27111518
[TBL] [Abstract][Full Text] [Related]
53. RNA interference and human disease.
Cheng JC; Moore TB; Sakamoto KM
Mol Genet Metab; 2003; 80(1-2):121-8. PubMed ID: 14567961
[TBL] [Abstract][Full Text] [Related]
54. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.
Bhindi R; Fahmy RG; Lowe HC; Chesterman CN; Dass CR; Cairns MJ; Saravolac EG; Sun LQ; Khachigian LM
Am J Pathol; 2007 Oct; 171(4):1079-88. PubMed ID: 17717148
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins.
Fraisier C; Abraham DA; van Oijen M; Cunliffe V; Irvine A; Craig R; Dzierzak EA
Gene Ther; 1998 Jul; 5(7):946-54. PubMed ID: 9813666
[TBL] [Abstract][Full Text] [Related]
56. [Antibiotics and vaccines should be used together in infectious diseases].
LEIBOVICH L; SALZMAN S
Dia Med; 1955 Nov; 27(82):2703-5. PubMed ID: 13285315
[No Abstract] [Full Text] [Related]
57. Gene therapy in immune-mediated diseases of the eye.
Pleyer U; Ritter T
Prog Retin Eye Res; 2003 May; 22(3):277-93. PubMed ID: 12852487
[TBL] [Abstract][Full Text] [Related]
58. An academic centre for gene therapy research with clinical grade manufacturing capability.
Islam KB; Blomberg P; Wikström K; Smith CI
Ann Med; 1997 Dec; 29(6):579-83. PubMed ID: 9562528
[TBL] [Abstract][Full Text] [Related]
59. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.
Smythe JA; Symonds G
Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023
[No Abstract] [Full Text] [Related]
60. Clinical translation of gene medicine.
Wang F; Qin Z; Lu H; He S; Luo J; Jin C; Song X
J Gene Med; 2019 Jul; 21(7):e3108. PubMed ID: 31246328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
